Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure

MP Busch, GA Satten - The American journal of medicine, 1997 - Elsevier
Rational application of diagnostic assays in the management of healthcare workers (HCWs)
following occupational exposure is needed to rule out pre-existing human immunodeficiency …

Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection

T Eastlund - Cell transplantation, 1995 - journals.sagepub.com
The incidence of cell transplant-transmitted infection is unknown and can only be inferred
from prospective studies–that have not yet been performed and reported. The possibility of …

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue …

MP Busch, LLL Lee, GA Satten, DR Henrard… - …, 1995 - Wiley Online Library
BACKGROUND: Almost all human immunodeficiency virus (HIV) transmission via blood or
tissues that has occurred since anti‐HIV screening was implemented in 1985 is traceable to …

Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1

JP Moore, Y Cao, DD Ho, RA Koup - Journal of virology, 1994 - Am Soc Microbiol
We have studied the development of the antibody response to the surface glycoprotein
gp120 of human immunodeficiency virus type 1 in three individuals who presented with …

Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests

R Brookmeyer, TC Quinn - American journal of epidemiology, 1995 - academic.oup.com
In sharp contrast to the considerable worldwide epidemiologic data available on acquired
immunodeficiency syndrome incidence and human immunodeficiency virus (HIV) …

Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays

B Weber, EH Mbargane Fall, A Berger… - Journal of Clinical …, 1998 - Am Soc Microbiol
In order to reduce the diagnostic window between the time of human immunodeficiency
virus (HIV) infection and laboratory diagnosis, new screening enzyme-linked …

Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay

L Gürtler, A Mühlbacher, U Michl, H Hofmann… - Journal of virological …, 1998 - Elsevier
In order to reduce the window phase between time of human immunodeficiency virus (HIV)
infection and laboratory diagnosis, new fourth generation screening assays which permit a …

Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody

LR Petersen, GA Satten, R Dodd, M Busch… - …, 1994 - Wiley Online Library
Background: For persons newly infected with the human immunodeficiency virus type 1 (HIV‐
1), the time from the onset of infectivity to the development of detectable HIV‐1 antibody is …

Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high …

B Weber, L Gürtler, R Thorstensson… - Journal of clinical …, 2002 - Am Soc Microbiol
Fourth-generation assays for the simultaneous detection of human immunodeficiency virus
(HIV) antigen and antibody that were available on the international market until now have …

Difficulties and strategies of HIV diagnosis

L Gürtler - The Lancet, 1996 - thelancet.com
HIV infection is commonly diagnosed by detection of antibodies (anti-HIV) by ELISA or
agglutination. Reactive results are confirmed by western blot (immunoblot) or further specific …